Parth Arvind Shah - JoVE Visualize

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Current Pharmaceutical Design|November 30, 2016

Glaucoma: Hot Topics in PharmacologyShiama I Balendra, Parth Arvind Shah, Mishank Jain, et al.

International Ophthalmology|March 18, 2026

Incidences and outcomes of retinal re-detachment in vitrectomised eyes following cataract extractionParth Arvind Shah, Neil Shah, Syed Ahmed, et al.

Movement Disorders : Official Journal of the Movement Disorder Society|October 13, 2018

Oculo-visual abnormalities in Parkinson's disease: Possible value as biomarkersLi Guo, Eduardo M Normando, Parth Arvind Shah, et al.

Eye (London, England)|March 2, 2026

Predictive factors for visual acuity in diabetic macular oedema: lessons for clinical practice learned from deferring intravitreal injections under the COVID-19 pandemicMarcela Bohn, Jose Carlo M Artiaga, Tjebo Heeren, et al.

Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Current Pharmaceutical Design|November 30, 2016

Glaucoma: Hot Topics in PharmacologyShiama I Balendra, Parth Arvind Shah, Mishank Jain, et al.

International Ophthalmology|March 18, 2026

Incidences and outcomes of retinal re-detachment in vitrectomised eyes following cataract extractionParth Arvind Shah, Neil Shah, Syed Ahmed, et al.

Movement Disorders : Official Journal of the Movement Disorder Society|October 13, 2018

Oculo-visual abnormalities in Parkinson's disease: Possible value as biomarkersLi Guo, Eduardo M Normando, Parth Arvind Shah, et al.

Eye (London, England)|March 2, 2026

Predictive factors for visual acuity in diabetic macular oedema: lessons for clinical practice learned from deferring intravitreal injections under the COVID-19 pandemicMarcela Bohn, Jose Carlo M Artiaga, Tjebo Heeren, et al.

Pageof 1